We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01259869
First Posted: December 14, 2010
Last Update Posted: April 13, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Cascadian Therapeutics Inc.
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Publications: